Mr Gregory T Czer, MD | |
754 Medical Center Ct, 100, Chula Vista, CA 91911 | |
(619) 421-4000 | |
(619) 421-6395 |
Full Name | Mr Gregory T Czer |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 754 Medical Center Ct, Chula Vista, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1932218963 | NPI | - | NPPES |
W10946 | Other | MEDICARE TRANSFER # |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | G41079 (California) | Secondary |
207R00000X | Internal Medicine | G41079 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Gregory T Czer, MD 754 Medical Center Ct, 100, Chula Vista, CA 91911 Ph: (619) 421-4000 | Mr Gregory T Czer, MD 754 Medical Center Ct, 100, Chula Vista, CA 91911 Ph: (619) 421-4000 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase II protocol for the clinical study of Archexin as a treatment of ovarian cancer to the U.S. Food and Drug Administration (FDA).
Give your medicine a jolt. By using - electrochemistry - a technique that combines electricity and chemistry, future pharmaceuticals - including many of the top prescribed medications in the United States - soon may be easily scaled up to be manufactured in a more sustainable way.
Public health experts can identify nations that are vulnerable to the occurrence and impact of future outbreaks of Ebola or other emergencies by using a screening tool that evaluates a nation's strengths across a wide range of measures such as political strength and health care capabilities, according to a new analysis from the RAND Corporation.
BSD Medical Corporation today reported clinical study data showing that hyperthermia, using the BSD-2000 Hyperthermia System, combined with chemotherapy has the potential to improve control rate and long-term survival for the treatment of children with high-risk cancer who have a dismal prognosis.
› Verified 2 days ago
Dr. Perry V Montoya, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 525 3rd Ave, Chula Vista, CA 91910 Phone: 858-499-2600 Fax: 619-585-4353 | |
John S Videen, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 752 Medical Center Ct, Suite 302, Chula Vista, CA 91911 Phone: 619-421-3361 Fax: 619-656-8936 | |
Daniel Cepin, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 890 Eastlake Pkwy, Suite 205, Chula Vista, CA 91914 Phone: 619-482-0300 Fax: 619-482-0959 | |
Kenneth Burton Johnson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 769 Medical Center Ct, Suite 202, Chula Vista, CA 91911 Phone: 619-482-8430 Fax: 619-482-8005 | |
Dr. Michael Sonbaty, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 E Palomar St, Chula Vista, CA 91913 Phone: 858-499-2616 | |
Sara Khandan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 835 Third Ave Ste A, Chula Vista, CA 91911 Phone: 619-425-7755 Fax: 619-425-2138 | |
Alejandro G Hinojosa, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 340 4th Ave, Suite 8, Chula Vista, CA 91910 Phone: 619-216-7546 Fax: 619-216-7783 |